Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Sell
27
HHS Quote, Financials, Valuation and Earnings
Last price:
$5.30
Seasonality move
:
5.28%
Day range:
$5.26 - $5.42
52-week range:
$5.26 - $8.87
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.21x
P/B ratio:
1.84x
Volume:
6.4K
Avg. volume:
22.5K
1-year change:
-24.39%
Market cap:
$38.6M
Revenue:
$191.5M
EPS (TTM):
-$4.11
Analysts' Opinion
-
Consensus RatingHarte-Hanks has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Harte-Hanks has an estimated upside of 230.19% from its current price of $5.30.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $5.30.
Fair Value
-
According to the consensus of 0 analysts, Harte-Hanks has 230.19% upside to fair value with a price target of -- per share.
HHS vs. S&P 500
-
Over the past 5 trading days, Harte-Hanks has underperformed the S&P 500 by -7.07% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Harte-Hanks does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Harte-Hanks has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Harte-Hanks reported revenues of $47.6M.
Earnings Growth
-
Harte-Hanks earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Harte-Hanks reported earnings per share of $0.02.
Enterprise value:
32.7M
EV / Invested capital:
1.55x
Price / LTM sales:
0.21x
EV / EBIT:
4.24x
EV / Revenue:
0.17x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-4.59x
Price / Operating cash flow:
165.56x
Enterprise value / EBITDA:
2.72x
Gross Profit (TTM):
$129.3M
Return On Assets:
-26.41%
Net Income Margin (TTM):
-15.91%
Return On Equity:
-146.3%
Return On Invested Capital:
-146.3%
Operating Margin:
5.74%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $203.5M | $196.8M | $187.6M | $47.1M | $47.6M | |
| Gross Profit | $146.7M | $134.1M | $129.3M | $31.7M | $33.2M | |
| Operating Income | $16M | $9.1M | $9.2M | $2.9M | $2.7M | |
| EBITDA | $22.2M | $7.1M | $12M | $3.9M | $3.8M | |
| Diluted EPS | $1.94 | $3.07 | -$4.11 | $0.08 | $0.02 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $91.6M | $82.5M | $80.6M | $62.2M | $53.8M | |
| Total Assets | $114.7M | $112.5M | $111.1M | $110.8M | $108.1M | |
| Current Liabilities | $50M | $42.4M | $45.8M | $38.7M | $36.9M | |
| Total Liabilities | $153.9M | $141.1M | $114.2M | $90.3M | $87.1M | |
| Total Equity | -$39.2M | -$28.7M | -$3.1M | $20.5M | $21M | |
| Total Debt | $27.1M | $13.1M | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $26.4M | $12.7M | -$2.7M | $1.5M | -$2.9M | |
| Cash From Investing | -$6.2M | -$7.3M | -$4M | -$222K | -$1.9M | |
| Cash From Financing | -$15M | -$12.5M | -$411K | -$818K | -$163K | |
| Free Cash Flow | $20.1M | $11.1M | -$7.1M | $1.3M | -$4.9M | |
HHS
Sector
Market Cap
$38.6M
$110M
Price % of 52-Week High
59.75%
66.47%
Dividend Yield
0%
0%
Shareholder Yield
0.57%
3.39%
1-Year Price Total Return
-24.39%
-16.31%
Beta (5-Year)
0.561
0.704
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$5.50
200-day SMA
Sell
Level
$7.26
Bollinger Bands (100)
Sell
Level
6.15 - 7.69
Chaikin Money Flow
Sell
Level
-7.6M
20-day SMA
Sell
Level
$5.65
Relative Strength Index (RSI14)
Sell
Level
31.39
ADX Line
Sell
Level
15.35
Williams %R
Buy
Level
-95.7447
50-day SMA
Sell
Level
$6.39
MACD (12, 26)
Sell
Level
-0.27
25-day Aroon Oscillator
Sell
Level
-96
On Balance Volume
Sell
Level
-18.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (11.8923)
Sell
CA Score
(Annual)
Level (-1.0733)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-9.3126)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
Stock Forecast FAQ
In the current month, HHS has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HHS average analyst price target in the past 3 months is --.
-
Where Will Harte-Hanks Stock Be In 1 Year?
According to analysts, the consensus estimate is that Harte-Hanks share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Harte-Hanks?
Analysts are divided on their view about Harte-Hanks share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Harte-Hanks is a Sell and believe this share price will drop from its current level to --.
-
What Is Harte-Hanks's Price Target?
The price target for Harte-Hanks over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HHS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Harte-Hanks is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of HHS?
You can purchase shares of Harte-Hanks via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Harte-Hanks shares.
-
What Is The Harte-Hanks Share Price Today?
Harte-Hanks was last trading at $5.30 per share. This represents the most recent stock quote for Harte-Hanks. Yesterday, Harte-Hanks closed at $5.30 per share.
-
How To Buy Harte-Hanks Stock Online?
In order to purchase Harte-Hanks stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 26
Power Solutions International [PSIX] is down 3.27% over the past day.
Buy
65
TSLL alert for Dec 26
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 3.32% over the past day.
Buy
75
SMLR alert for Dec 26
Semler Scientific [SMLR] is up 0.32% over the past day.
